N,N-dimethyl phytosphingosine (
DMPS) blocks the conversion of
sphingosine to
sphingosine-1-phosphate (S1P) by the
enzyme sphingosine kinase (SK). In this study, we elucidated the apoptotic mechanisms of
DMPS action on a human
leukemia cell line using functional pharmacologic and genetic approaches. First, we demonstrated that
DMPS-induced apoptosis is evidenced by nuclear morphological change, distinct internucleosomal DNA fragmentation, and an increased sub-G1 cell population.
DMPS treatment led to the activation of
caspase-9 and
caspase-3, accompanied by the cleavage of
poly(ADP-ribose) polymerase (PARP) and led to
cytochrome c release, depolarization of the mitochondrial membrane potential, and downregulation of the anti-apoptotic members of the bcl-2 family. Ectopic expression of bcl-2 and bcl-xL conferred resistance of HL-60 cells to
DMPS-induced cell death, suggesting that
DMPS-induced apoptosis occurs predominantly through the activation of the intrinsic mitochondrial pathway. We also observed that
DMPS activated the caspase-8-Bid-Bax pathway and that the inhibition of
caspase-8 by
z-IETD-fmk or
small interfering RNA suppressed the cleavage of Bid,
cytochrome c release,
caspase-3 activation, and apoptotic cell death. In addition, cells subjected to
DMPS exhibited significantly increased
reactive oxygen species (ROS) generation, and ROS scavengers, such as
quercetin and
Tiron, but not
N-acetylcysteine (NAC), inhibited
DMPS-induced activations of
caspase-8, -3 and subsequent apoptotic cell death, indicating the role of ROS in caspase-8-mediated apoptosis. Taken together, these results indicate that
caspase-8 acts upstream of
caspase-3, and that the caspase-8-mediated mitochondrial pathway is important in
DMPS-induced apoptosis. Our results also suggest that ROS are critical regulators of caspase-8-mediated apoptosis in
DMPS-treated
leukemia cells.